Interactome Biotherapeutics
Pre-clinicalInteractome is advancing its novel biologic platform, a next-generation, multi-targeted Secretome containing hundreds of biologically active proteins and other factors crucial for cellular regeneration, the modulation of inflammation, cell recovery and turnover. We believe this novel platform holds significant clinical potential across a range of important underserved conditions in neurology, oncology, and cardiology.
About
Interactome is advancing its novel biologic platform, a next-generation, multi-targeted Secretome containing hundreds of biologically active proteins and other factors crucial for cellular regeneration, the modulation of inflammation, cell recovery and turnover. We believe this novel platform holds significant clinical potential across a range of important underserved conditions in neurology, oncology, and cardiology.
Funding History
1Total raised: $5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile